CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.011.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.22M | -5.19M | -31.04M | -31.19M | -24.27M |
| Total Depreciation and Amortization | -- | -- | 2.46M | 2.47M | -- |
| Total Amortization of Deferred Charges | -- | -- | 175.60K | 176.40K | -- |
| Total Other Non-Cash Items | -8.35M | -8.31M | 14.03M | 14.10M | 6.60M |
| Change in Net Operating Assets | -- | -- | 3.69M | 3.71M | -- |
| Cash from Operations | -13.57M | -13.49M | -10.69M | -10.74M | -17.67M |
| Capital Expenditure | -- | -- | -930.40K | -934.90K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -20.10K | -20.20K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 118.60K | 117.90K | 1.36M | 1.37M | 454.60K |
| Cash from Investing | 118.60K | 117.90K | 412.70K | 414.70K | 454.60K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 65.00M |
| Total Debt Repaid | -48.50M | -48.50M | -22.93M | -22.93M | -4.50M |
| Issuance of Common Stock | 9.00M | 9.00M | 21.46M | 21.46M | -- |
| Repurchase of Common Stock | -15.50M | -15.50M | -- | -- | -46.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 40.18M | 40.18M | -1.65M | -1.65M | -2.16M |
| Cash from Financing | -2.05M | -2.04M | -433.10K | -435.20K | 1.70M |
| Foreign Exchange rate Adjustments | 412.30K | 409.90K | -1.35M | -1.36M | 1.90M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.09M | -15.00M | -12.06M | -12.12M | -13.61M |